ArticleClinical cancer research : an official journal of the American Association for Cancer Research2012

Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.

Shaoman Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.